Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Assets
Current assets
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net
Inventory
Promissory note due from related party
Prepaid expenses and other current assets
Current assets held for sale
Total current assets
Cash and marketable securities held in Trust Account
Property and equipment, net
Operating lease, right-of-use assets, net
Goodwill
Intangible assets, net
Security deposits
Total assets
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Accrued expenses and other liabilities
Convertible promissory note - related party
Warrant liability
Current portion of long-term debt
Operating lease liabilities, current
Finance lease liability, current
Other financing obligations, current
Deferred revenue
Total current liabilities
Operating lease liabilities, net of current portion
Deferred tax liabilities, net
Warrant liabilities
Long-term debt
Finance lease liability, net of current portion
Other financing obligations
Other financing obligations, net of current portion
Long-term debt, net of current portion
Total liabilities
Ordinary shares subject to possible redemption, 13,800,000 and 13,068,649 shares at $10.00 redemption value at June 30, 2021 and December 31, 2020, respectively
Stockholders’ equity
Preferred stock ($0.0001 par value; 10,000,000 shares authorized; none issued and outstanding as of December 31, 2023 and 2022, respectively)
Common stock ($0.0001 par value; 120,000,000 shares authorized; 6,597,409 and 6,180,646 shares issued and outstanding as of December 31, 2023 and 2022, respectively) (1)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support